<DOC>
	<DOCNO>NCT00977028</DOCNO>
	<brief_summary>This pharmacokinetic clinical trial dose range study lidocaine tumescent local anesthesia . The goal understand absorption pharmacokinetic tumescent lidocaine determine objective ( statistical ) estimate maximum safe mg/kg dosage lidocaine tumescent local anesthesia without liposuction .</brief_summary>
	<brief_title>Tumescent Lidocaine Maximum Safe mg/kg Dosage</brief_title>
	<detailed_description>Background : Tumescent local anesthesia ( TLA ) permit wide variety therapeutic surgical procedure subcutaneous tissue skin perform totally local anesthesia ( ) . Infiltration sufficient volume TLA cause target tissue become temporarily tumescent , swollen firm . TLA define subcutaneous infiltration large volume tumescent local anesthetic solution ( TLAS ) . The safe use TLA require safe formulation safe use tumescent local anesthetic solution ( TLAS ) . By definition TLAS contain dilute lidocaine ( ≤ 1 gm/liter = 0.1 % ) epinephrine ( ≤ 1 mg/liter = 1:1,000,000 ) sodium bicarbonate ( 10 milliequivalents/liter ) physiologic crystalloid solution . Bicarbonate , essential ingredient , neutralizes acid pH commercial lidocaine epinephrine thereby eliminate intense sting discomfort often associate infiltration commercial local anesthetic . Lidocaine infiltrate TLA refer tumescent lidocaine . The FDA-approved maximum recommend dosage 7 mg/kg lidocaine epinephrine infiltration local anesthesia . However TLA much large mg/kg dosage lidocaine use . The safety efficacy TLA base unexpected slow lidocaine absorption associate large volume dilute lidocaine epinephrine infiltrate subcutaneous tissue . Published estimate maximum safe mg/kg dosage tumescent lidocaine derive liposuction patient range 35 mg/kg 55 mg/kg ( ) much high lidocaine dos without evident toxicity report . Liposuction , cosmetic surgical procedure remove subcutaneous fat , also remove tumescent lidocaine thereby reduce lidocaine bioavailability . In contrast , therapeutic surgery usually remove subcutaneous lidocaine therefore bioavailability lidocaine relatively increased peak serum lidocaine concentration ( Cmax ) risk lidocaine toxicity . Because TLA use surgical procedure unrelated liposuction , desirable reliable estimate maximum safe dosage tumescent lidocaine base clinical data subject liposuction . The goal present study obtain reliable estimate maximum safe mg/kg dosage lidocaine tumescent local anesthesia without subsequent liposuction . The plan present pharmacokinetic study involve follow step : 1 . Show significant difference bioavailability tumescent lidocaine without liposuction . This validate need determine maximum safe mg/kg dosage tumescent lidocaine without liposuction . 2 . Show magnitude peak serum lidocaine concentration linear function mg/kg dosage tumescent lidocaine , without liposuction . This support use interpolation extrapolation discussion result . 3 . For specified mg/kg dosage tumescent lidocaine , estimate risk peak serum lidocaine concentration exceed 6 µg/ml toxic threshold . Methods : The protocol consent form research approve institutional review board . All clinical procedure conduct within accredited ambulatory surgery center . Serum lidocaine concentration measure high pressure flame chromatography ( HPFC ) . Female volunteer subject participate three procedure . Each procedure involve infiltrate TLA follow sequential serum sample obtain peripheral vein via plastic catheter time ( T ) = 0 , 2 , 4 , 6 , 8 , 10 , 12 , 14 , 16 , 18 24 hour assay lidocaine concentration HPFC . For procedure , mg/kg dosage tumescent lidocaine correspond peak maximum serum lidocaine concentration ( Cmax ) record . The area target infiltration tumescent local anesthesia ( TLA ) vary subject subject include abdomen , hip , outer thigh , inner thigh knee , female breast , lateral thorax back . For subject , first two investigative procedure involve infiltration TLA without subsequent liposuction ; third procedure subject receive TLA follow liposuction . Thus patient serf control . Liposuction initiate one two hour completion infiltration process . For subject TLA infiltration area sequential infiltration separate least two week . As compensation participation three clinical study , procedure require 24 hour , patient receive liposuction target area cost . The total mg/kg dosage tumescent lidocaine vary patient different procedure within patient . An individual patient receive mg/kg dosage tumescent lidocaine least two occasion , follow liposuction least without liposuction . Some patient receive dosage tumescent lidocaine three procedure . Similarly , order explore effect vary concentration lidocaine concentration epinephrine within TLA solution understand effect vary mg/kg dosage TLA , patient factor vary . In order determine liposuction significantly affect amount lidocaine enters systemic circulation , bioavailability associate tumescent lidocaine without liposuction compare . The statistical significance difference area curve ( AUC ) without liposuction AUC liposuction calculate For procedure , graph sequential serum lidocaine concentration C ( T ) function time ( T ) drawn peak serum lidocaine concentration time record liposuction without liposuction . Confidence interval determine order estimate risk , give mg/kg dosage , Cmax exceed toxic threshold lidocaine .</detailed_description>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>Healthy female ( ASA class 1 2 ) Desires liposuction Easily accessible vein History Hepatitis C , HIV ASA class great equal 3</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Tumescent</keyword>
	<keyword>Local Anesthesia</keyword>
	<keyword>Lidocaine</keyword>
	<keyword>Dosage Maximum</keyword>
	<keyword>Subcutaneous infiltration</keyword>
	<keyword>maximum Safe mg per kg dosage lidocaine</keyword>
	<keyword>Tumescent Local Anesthesia</keyword>
</DOC>